Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Niva Bupa Health Insurance Company Limited (NIVABUPA.NS)

82.19
+0.60
+(0.74%)
At close: 3:30:00 PM GMT+5:30
Loading Chart for NIVABUPA.NS
  • Previous Close 81.59
  • Open 81.75
  • Bid --
  • Ask --
  • Day's Range 81.34 - 84.40
  • 52 Week Range 68.54 - 109.34
  • Volume 1,678,249
  • Avg. Volume 1,899,103
  • Market Cap (intraday) 150.241B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 91.32
  • EPS (TTM) 0.90
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 86.20

Niva Bupa Health Insurance Company Limited provides health insurance products in India. It underwrites individual and family health, critical illness, and personal accident insurance plans, as well as travel insurance. Niva Bupa Health Insurance Company Limited was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited operates as a subsidiary of Bupa Singapore Holdings Pte. Ltd.

www.nivabupa.com

8,876

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NIVABUPA.NS

View More

Performance Overview: NIVABUPA.NS

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

NIVABUPA.NS
2.28%
S&P BSE SENSEX (^BSESN)
3.02%

1-Year Return

NIVABUPA.NS
5.18%
S&P BSE SENSEX (^BSESN)
7.90%

3-Year Return

NIVABUPA.NS
5.18%
S&P BSE SENSEX (^BSESN)
41.29%

5-Year Return

NIVABUPA.NS
5.18%
S&P BSE SENSEX (^BSESN)
138.75%

Compare To: NIVABUPA.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NIVABUPA.NS

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    149.14B

  • Enterprise Value

    148.13B

  • Trailing P/E

    90.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.05

  • Price/Book (mrq)

    4.61

  • Enterprise Value/Revenue

    3.03

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.12%

  • Return on Assets (ttm)

    1.50%

  • Return on Equity (ttm)

    4.86%

  • Revenue (ttm)

    52.74B

  • Net Income Avi to Common (ttm)

    1.65B

  • Diluted EPS (ttm)

    0.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.5B

  • Total Debt/Equity (mrq)

    6.59%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NIVABUPA.NS

View More

Company Insights: NIVABUPA.NS

Research Reports: NIVABUPA.NS

View More

People Also Watch